摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Methyl-6,7-dihydroxanthyletin | 39112-66-8

中文名称
——
中文别名
——
英文名称
4-Methyl-6,7-dihydroxanthyletin
英文别名
4,8,8-trimethyl-7,8-dihydro-2H,6H-pyrano[3,2-g]chromen-2-one;2,2,6-trimethyl-3,4-dihydropyrano[3,2-g]chromen-8-one
4-Methyl-6,7-dihydroxanthyletin化学式
CAS
39112-66-8
化学式
C15H16O3
mdl
MFCD06492885
分子量
244.29
InChiKey
UYWBIHHNIMDFDF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    18
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-Methyl-6,7-dihydroxanthyletin 在 selenium(IV) oxide 、 双氧水溶剂黄146 作用下, 以 xylene 为溶剂, 反应 84.0h, 生成 4-Carboxy-6,7-dihydroxanthyletin
    参考文献:
    名称:
    Waykole, Pratibha; Shaikh, Salim; Usgaonkar, R. N., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1980, vol. 19, # 3, p. 238 - 240
    摘要:
    DOI:
  • 作为产物:
    描述:
    间苯二酚ascorbic acid硫酸柠檬酸 作用下, 反应 22.25h, 生成 4-Methyl-6,7-dihydroxanthyletin
    参考文献:
    名称:
    Pancreatic α-amylase inhibition and free radical scavenging activity of substituted pyranochromenone derivatives
    摘要:
    Pyranochromenone derivatives 3a-d, 6a-j and 2H-chromenones 8a-b were synthesized and screened for their in vitro alpha-amylase inhibitory and ABTS(aEuro cent+) [2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)] free radical scavenging activities. Compounds 3a, 3c, and 6d displayed dual function of ABTS(aEuro cent+) radical scavenging as well as alpha-amylase inhibition. Compound 6h was found to be most potent alpha-amylase inhibitor in present series of compounds. Docking studies suggest that these compounds occupy active site of the human pancreatic alpha-amylase similar to that of acarbose which inhibits enzyme by hydrophobic interactions. These compounds have potential to be developed as therapeutics targeted against diet-induced hyperglycemia in diabetes.Series of pyranochromenone derivatives 3a-d, 6a-j, and 8a-b were synthesized, among these compound 6h shown potent intestinal alpha-amylase inhibitory activity. Compounds 3a, 3c, and 6d were shown dual properties such as alpha-amylase inhibitory and antioxidant activities. These derivatives may serve as a model compounds for design and development of therapeutics based agents.
    DOI:
    10.1007/s00044-013-0867-y
点击查看最新优质反应信息

文献信息

  • Novel syntheses of dihydroxanthyletin and dihydroseselin derivatives
    作者:Michele M. Jetter、Ned D. Heindel、Jeffrey D. Laskin
    DOI:10.1002/jhet.5570270433
    日期:1990.5
    In a one-step alkylation, ring-closure 7-hydroxycoumarins are condensed in acid media with allyl and homoallyl halides or alcohols to linear 6,7-dihydro-2H,8H-benzo[1,2–6:5,4-b']dipyran-2-ones. If both carbon-6 and carbon-8 are unsubstituted in the original coumarin, cyclization to angular isomers 9,10-dihydro-2H,8H-benzo[1,2–6:3,4-b']dipyran-2-ones competes. These compounds are higher ring homologs
    在一步式烷基化中,将闭环的7-羟基香豆素在酸介质中与烯丙基和高烯丙基卤化物或醇缩合成线性6,7-二氢-2 H,8 H-苯并[1,2–6:5,4 - b” ] dipyran -2-酮。如果原始香豆素中的碳6和碳8都未被取代,则环化成角异构体9,10-dihydro-2 H,8 H-苯并[1,2-6:3,4- b' ] dipyran-2 -竞争。这些化合物是通常用于皮肤疾病的光疗中的补骨脂素和当归素的较高环同系物。
  • Kanvinde, M.N.; Kulkarni, S.A.; Paradkar, M.V., Synthetic Communications, 1990, vol. 20, # 21, p. 3259 - 3264
    作者:Kanvinde, M.N.、Kulkarni, S.A.、Paradkar, M.V.
    DOI:——
    日期:——
  • Pathak, S. D.; Mujumdar, A. S.; Usgaonkar, R. N., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1982, vol. 21, p. 767 - 768
    作者:Pathak, S. D.、Mujumdar, A. S.、Usgaonkar, R. N.
    DOI:——
    日期:——
  • Reaction of 2,2-Dimethylchromans with 2,3-Dichloro-5,6-dicyanobenzoguinone (DDQ)
    作者:V. K. Ahluwalia、R. S. Jolly
    DOI:10.1055/s-1982-29707
    日期:——
  • SHAIKH S.; USAONKAR R. N., INDIAN J. CHEM., 1979, B 18, NO 5, 405-408
    作者:SHAIKH S.、 USAONKAR R. N.
    DOI:——
    日期:——
查看更多